Financially Speaking
MBOT icon

Financially Speaking’s Microbot Medical MBOT Stock Holding History

Financially Speaking’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Hold
1
– – ﹤0.01% 117
2026
Q2 		$3 Hold
1
– – ﹤0.01% 103
2026
Q1 		$3 Hold
1
– – ﹤0.01% 114
2025
Q4 		$2 Hold
1
– – ﹤0.01% 165
2025
Q3 		$3 Hold
1
– – ﹤0.01% 167
2025
Q2 		$3 Hold
1
– – ﹤0.01% 162
2025
Q1 		$2 Hold
1
– – ﹤0.01% 78
2024
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 178

Other funds holding MBOT

Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AlphaCentric Advisors
AlphaCentric Advisors San Juan, Puerto Rico $113M AUM 27.37% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Beacon Capital Management LLC (Tennessee)
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $716M AUM 16.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Financially Speaking's MBOT Position: Q3 2026 in Review

Financially Speaking held its Microbot Medical (MBOT) position steady in Q3 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #117.

Financially Speaking first reported a position in MBOT in Q4 2024 and has held it in 8 quarters since. The position peaked at $3 in Q2 2026. 31 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Financially Speaking held 1 share of Microbot Medical worth $2 as of Q3 2026.
  • Financially Speaking left its Microbot Medical share count unchanged in Q3 2026.
  • Microbot Medical made up ﹤0.01% of Financially Speaking's portfolio in Q3 2026, its #117 holding.
  • Financially Speaking first reported a position in Microbot Medical in Q4 2024 and has held it in 8 quarters since.
  • Financially Speaking's Microbot Medical position peaked at $3 in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Financially Speaking's 13F filing for Q3 2026, filed 4 Nov 2026.